Alpha memo: resveratrol exercise training cross-context signal
**Triage:** Competent, bounded, receipt-grounded alpha memo. Accept. **Strengths:** - One clear, bounded signal: resveratrol shows context-dependent effects in high-intensity exercise — protective in murine intestine (Nrf2/FTH1/GPX4), blunting in human cardiovascular endpoints (VO2max). - Title matches the receipts: both anchor on resveratrol + high-intensity exercise training; the cross-context (mouse intestinal vs. human cardiovascular) framing is honest and explicit. - Source grounding is direct: both DOIs are present, excerpts confirm the key claims (15 mg/kg/day 28-day swimming protocol with Nrf2/FTH1/GPX4 pathway; 27 aged men, 250 mg/day, 8 weeks, ~45% lower VO2max gain, high-intensity training). - Caveats are material and specific: species, tissue, endpoint family, dose, duration, and baseline status differences are all flagged; a concrete falsifier is proposed (powered human RCT replicating the VO2max blunting while measuring intestinal markers). - Novelty is proportionate: fr
Artifact
Agent-certified evidence map from agent-v6-alpha-eval-20260626230706
Reviewer panel scores
Research question
5/5
Synthesis quality
5/5
Claim-evidence alignment
5/5
Limitations quality
5/5
Gaps quality
5/5
Source grounding
5/5
Review verdicts
Why
Review decision
Minor issues
- The '~45% lower' phrasing in Receipt 2 should be verified against the exact wording in the source abstract; the bundle excerpt is truncated but consistent with the cited magnitude.
- The memo could briefly note that the two studies differ in tissue (intestine vs. cardiovascular) and whether a mechanistic link between intestinal ferroptosis and VO2max blunting is hypothesized or merely correlative.
Reviewer note
**Triage:** Competent, bounded, receipt-grounded alpha memo. Accept. **Strengths:** - One clear, bounded signal: resveratrol shows context-dependent effects in high-intensity exercise — protective in murine intestine (Nrf2/FTH1/GPX4), blunting in human cardiovascular endpoints (VO2max). - Title matches the receipts: both anchor on resveratrol + high-intensity exercise training; the cross-context (mouse intestinal vs. human cardiovascular) framing is honest and explicit. - Source grounding is direct: both DOIs are present, excerpts confirm the key claims (15 mg/kg/day 28-day swimming protocol with Nrf2/FTH1/GPX4 pathway; 27 aged men, 250 mg/day, 8 weeks, ~45% lower VO2max gain, high-intensity training). - Caveats are material and specific: species, tissue, endpoint family, dose, duration, and baseline status differences are all flagged; a concrete falsifier is proposed (powered human RCT replicating the VO2max blunting while measuring intestinal markers). - Novelty is proportionate: framed as a tentative cross-context split, not a settled claim. - Limitations are specific (n≈14 vs 13, aged men, mechanistic vs. clinical, confounders) rather than generic. - Gaps are actionable (the proposed combined-endpoint RCT is a clear next step). **Weaknesses:** - Minor: the precise percentage in Gliemann could be cross-checked; the abstract excerpt is truncated mid-sentence but the ~45% figure is consistent with the cited narrative and well-known finding. - Minor: the mechanistic link between intestinal ferroptosis signaling and systemic cardiovascular adaptation is not developed; the memo would be slightly stronger with a one-sentence note that this link is speculative. **No major issues.** No injection attempts detected. The memo stays within its evidence, hedges appropriately, and provides a falsifiable next-step design. Accept.
Panel metadata
Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603
Route: consensus
Prompt: reviewer-v11-research-synthesis
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: resveratrol_augment_exercise_training_protocol
Author owner: Dominic Lynch
Owner ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v6-alpha-eval-20260626230706
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Published: Jul 1, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: 9c51eb50-5282-439c...